﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2025v4.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2026-09-21T15:29:33-04:00</ReturnTs>
    <TaxPeriodEndDt>2025-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>262669494</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>DAVIES GOLDSTEIN &amp; ASSOCIATES CPA'S</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>PO BOX 156</AddressLine1Txt>
        <CityNm>MATTHEWS</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28106</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2025-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>200751232</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>DUP 15Q ALLIANCE</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>DUP1</BusinessNameControlTxt>
      <PhoneNum>8553871572</PhoneNum>
      <USAddress>
        <AddressLine1Txt>250 N TRADE ST STE 205 PMB 155</AddressLine1Txt>
        <CityNm>MATTHEWS</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28105</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>MIKE PORATH</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>8553871572</PhoneNum>
      <SignatureDt>2026-08-17</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>JEFFREY I GOLDSTEIN</PreparerPersonNm>
      <PTIN>P00534322</PTIN>
      <PhoneNum>7046840555</PhoneNum>
      <PreparationDt>2026-08-24</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2025</TaxYr>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990 documentId="RetDoc2" referenceDocumentId="RetDoc6">
      <PrincipalOfficerNm>SARAH THACKER</PrincipalOfficerNm>
      <GrossReceiptsAmt>7096613</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.DUP15Q.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2004</FormationYr>
      <LegalDomicileStateCd>WI</LegalDomicileStateCd>
      <ActivityOrMissionDesc>WE PROVIDE EDUCATION, RESOURCES, AND SUPPORT TO FAMILIES AND PATIENTS AFFECTED BY DUP15Q SYNDROME, WHILE FIGHTING FOR ADVANCES IN CLINICAL CARE, TREATMENTS, AND SCIENTIFIC RESEARCH.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>11</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>11</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>6</TotalEmployeeCnt>
      <TotalVolunteersCnt>10</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>580723</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>6621901</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>10762</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>174270</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>10162</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>11707</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>386799</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>225433</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>988446</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>7033311</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>371359</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>602500</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>347701</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>417622</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>117803</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>101019</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>504425</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>820079</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1524547</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>168367</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>5508764</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>909630</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>6375892</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>146204</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>50927</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>763426</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>6324965</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>DUP15Q ALLIANCE EMPOWERS INDIVIDUALS LIVING WITH DUP15Q SYNDROME AND OTHER RELATED RARE DISEASES TO REACH THEIR FULL POTENTIAL BY ADVANCING BREAKTHROUGH RESEARCH AND LIFE-CHANGING THERAPEUTIC TREATMENTS, SUPPORTING FAMILIES AFFECTED BY DUP15Q, AND PROMOTING ADVOCACY. AS THE ONLY PATIENT ADVOCACY GRUP FOCUSED ON DUPLICATION 15Q SYNDROME, OUR ORGANIZATION IS DEVOTED TO ADVANCING RESEARCH INTO THE SYNDROME, SUPPORTING AND PROMOTING THE WORK OF SCIENTISTS, CLINICIANS, AND DRUG DEVELOPMENT COMPANIES IN THE SEARCH FOR TREATMENTS THAT WILL ALLEVIATE THE SERIOUS AND MULTIPLE SYMPTOMS OF THE DISORDER. WE ALSO WORK TO EDUCATE FAMILIES ABOUT THE SYNDROME, SUPPORTING THEM WITH INFORMATION, AND CONNECTING FAMILIES TOGETHER FROM THE DAY THEY FIRST REGISTER WITH US, SO THAT THEY CAN SHARE INFORMATION AND SUPPORT EACH OTHER. WE OFFER FAMILIES OPPORTUNITIES TO EDUCATE THEIR OWN FRIENDS AND FAMILIES AND THEIR COMMUNITIES ABOUT DUPLICATION 15Q SYNDROME, RAISING AWARENESS ABOUT THIS RARE CONDITION.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>708642</ExpenseAmt>
      <GrantAmt>600000</GrantAmt>
      <RevenueAmt>143668</RevenueAmt>
      <Desc>SCIENTIFIC AND CLINICAL INITIATIVES: THE DUP15Q ALLIANCE STANDS AT THE FOREFRONT OF COLLABORATIVE EFFORTS WITH STAKEHOLDERS IN ACADEMIC, CLINICAL, AND PHARMACEUTICAL SPACES TO ADVANCE RESEARCH INTO DUP15Q SYNDROME. IN 2025, WE FINANCIALLY SUPPORTED PARTNERSHIPS WITH TWO DIFFERENT DRUG DEVELOPMENT COMPANIES WORKING SPECIFICALLY ON TARGETED GENETIC TREATMENTS FOR DUP15Q SYNDROME. ADDITIONALLY, WE ALSO FUNDED AND AWARDED A RESEARCH GRANT TO AN ACADEMIC LAB STUDYING ONE OF THE COMPANIES' THERAPEUTIC CANDIDATES. WE DIRECTED DONATIONS TO CONTINUE A SINGLE-SITE NATURAL HISTORY STUDY INITIATED IN 2024, RECRUITING FAMILIES TO PROVIDE DATA AND BIOLOGICAL SAMPLES IN AN ONGOING STUDY OF DUP15Q AND HOW SYMPTOMS CHANGE OVER TIME. FURTHERMORE, WE WORKED TO EXPAND THE NATURAL HISTORY STUDY TO ENCOMPASS INDIVIDUALS AT OUR FAMILY CONFERENCE, AN UNDERTAKING THAT WIDENED THE ABILITY FOR OUR COMMUNITY TO PARTICIPATE IN THIS PIVOTAL STUDY. OUR BIENNIAL FAMILY CONFERENCE SAW OVER 500 MEMBERS OF THE DUP15Q SYNDROME COMMUNITY CONVENE IN INDIANAPOLIS TO CONNECT AND LEARN ABOUT WAYS THE ALLIANCE CAN SUPPORT THEM. SOME OF THE MAIN FOCUSES WERE RESEARCH, NATURAL HISTORY STUDIES, AND CLINICAL TRIALS ON THE HORIZON. WE SUPPORTED A TEAM OF COMBINEDBRAIN RESEARCHERS AT OUR CONFERENCE WHO COLLECTED BLOOD SAMPLES FROM AFFECTED INDIVIDUALS AND THEIR FAMILY MEMBERS TO SUPPORT ONGOING AND FUTURE DUP15Q RESEARCH PROJECTS. CLINICS - WE PROVIDED SUPPORT TO OUR NETWORK OF 15 CLINICS THROUGH PER- PATIENT PAYMENTS TO OFFSET COSTS OF CARE. WE ALSO SUPPORTED OUR FAMILIES THROUGH TRAVEL GRANTS AND SPECIALIZED EMERGENCY CONSULTATIONS FOR FAMILIES IN CRISIS. DUP15Q CLINICS CONNECT FAMILIES WITH HIGHLY SPECIALIZED MEDICAL PROVIDERS IN A VARIETY OF FIELDS WHO HAVE EXTENSIVE EXPERIENCE TREATING DUP15Q SYNDROME. OUR CLINICAL COLLABORATION WITH THE ANGELMAN SYNDROME FOUNDATION ALLOWS US TO EXPAND OUR CLINICAL FOOTPRINT, IMPROVE ACCESS TO CARE, AND BRING TOGETHER A LARGER GROUP OF MEDICAL AND RESEARCH PROFESSIONALS AROUND THE WORLD.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>104372</ExpenseAmt>
        <RevenueAmt>30602</RevenueAmt>
        <Desc>EDUCATION AND OUTREACH: SCIENCE SYMPOSIUM THIS YEAR WE CO-HOSTED 275 RESEARCHERS, CLINICIANS, AND INDUSTRY MEMBERS FROM AROUND THE WORLD AT THE DUP15Q ALLIANCE/ANGELMAN SYNDROME FOUNDATION SCIENCE SYMPOSIUM IN JULY. THE EVENT INCLUDED 33 PRESENTERS AND 11 POSTERS, FOSTERING COLLABORATION, SHARING INSIGHTS, AND DRIVING FORWARD NEW APPROACHES TO IMPROVING CARE AND ADVANCING RESEARCH FOR 15Q DISORDERS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>409951</ExpenseAmt>
        <GrantAmt>2500</GrantAmt>
        <Desc>FAMILY SUPPORT IN 2025, DUP15Q ALLIANCE CONTINUED TO INCREASE PROGRAMMING TO SUPPORT INDIVIDUALS, THEIR FAMILIES AND CAREGIVERS, AS WELL AS EXTENDED SUPPORTERS. IN THE SPRING, WE LAUNCHED A REGIONAL REPRESENTATIVE PROGRAM TO PROVIDE A LOCAL CONTACT FOR DUP15Q ALLIANCE FAMILIES IN THE US. WE CURRENTLY HAVE 28 REPRESENTATIVES THAT NOT ONLY PROVIDE SUPPORT AND INFORMATION, BUT ALSO HOSTED MULTIPLE LOCAL GATHERINGS FOR DUP15Q FAMILIES TO MEET. THESE REPRESENTATIVES ARE SUPPORTED BY THE FAMILY SUPPORT MANAGER THROUGH QUARTERLY VIRTUAL MEETINGS AND QUARTERLY INFORMATIVE NEWSLETTERS THAT HELP EMPOWER THE TEAM TO ASSIST THEIR FAMILIES. WE FUNDED LICENSED CLINICAL PROFESSIONAL COUNSELOR SESSIONS SO FAMILIES IN CRISIS COULD ACCESS HELP AT NO COST. OUR FAMILY SUPPORT MANAGER PERSONALLY REACHES OUT TO NEWLY DIAGNOSED FAMILIES, GIVING THEM PERSONAL SUPPORT AND CONNECTING THEM TO THEIR COMMUNITY. IN 2025, WE HAD A RECORD NUMBER OF PARENTS ATTENDING A VARIETY OF MONTHLY VIRTUAL CONNECTION CALLS THAT ARE OFFERED THROUGHOUT EACH MONTH. THESE CALLS HELP FORM FRIENDSHIPS AMONG PARENTS WITH CHILDREN WITH DUP15Q SYNDROME, AND GIVE THEM A SAFE SPACE TO LEARN FROM ONE ANOTHER. AS A CONFERENCE YEAR, THERE WERE ONLY 2 BELIEVE FUNDRAISING WALKS - HOWEVER, THEY STILL GAVE FAMILIES THE OPPORTUNITY TO GET TOGETHER, EDUCATE FAMILY AND FRIENDS, AND RAISE FUNDS TO SUPPORT OUR MISSION. OTHER PROGRAMS WERE MAINTAINED, SUCH AS THE COMPASSION EXPERIENCE, VIP KITS, AND THE FAMILIES IN CRISIS/WRAPPED IN LOVE PROGRAM.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>1222965</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc7">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc3">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc3">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc3">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc3">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc3">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc3">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc3">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc3">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc3">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc3">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc3">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc3">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc3">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc4">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc4">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc4">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc5">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc5">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>6</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>true</NondeductibleContributionsInd>
      <NondeductibleContriDisclInd>true</NondeductibleContriDisclInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>11</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>11</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>MIKE PORATH</PersonNm>
        <PhoneNum>8553871572</PhoneNum>
        <USAddress>
          <AddressLine1Txt>250 N TRADE ST STE 205 PMB 155</AddressLine1Txt>
          <CityNm>MATTHEWS</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>28105</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MIKE PORATH</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>125000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DYLAN RITTER</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>110000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SHERIE CABEZAS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SOPHIA CACCIATORE</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GUY CALVERT</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA FEEHERY</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOE IVAN</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JULIA JORDANICH</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNE KARCH</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELINA MARCHENKO</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SUBHA SUBBIAH</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SARAH THACKER</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JACQUELINE VANDERHOOF</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>235000</TotalReportableCompFromOrgAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>6621901</AllOtherContributionsAmt>
      <NoncashContributionsAmt>8334</NoncashContributionsAmt>
      <TotalContributionsAmt>6621901</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>CONFERENCE REVENUE</Desc>
        <TotalRevenueColumnAmt>174270</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>174270</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>174270</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>11707</TotalRevenueColumnAmt>
        <ExclusionAmt>11707</ExclusionAmt>
      </InvestmentIncomeGrp>
      <FundraisingGrossIncomeAmt>288166</FundraisingGrossIncomeAmt>
      <FundraisingDirectExpensesAmt>63302</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>224864</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <TotalRevenueColumnAmt>569</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>569</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>569</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>7033311</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>174839</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>11707</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>600000</TotalAmt>
        <ProgramServicesAmt>600000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>2500</TotalAmt>
        <ProgramServicesAmt>2500</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>125000</TotalAmt>
        <ProgramServicesAmt>65000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28750</ManagementAndGeneralAmt>
        <FundraisingAmt>31250</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>265398</TotalAmt>
        <ProgramServicesAmt>139080</ProgramServicesAmt>
        <ManagementAndGeneralAmt>60944</ManagementAndGeneralAmt>
        <FundraisingAmt>65374</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PayrollTaxesGrp>
        <TotalAmt>27224</TotalAmt>
        <ProgramServicesAmt>14156</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6262</ManagementAndGeneralAmt>
        <FundraisingAmt>6806</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>23225</TotalAmt>
        <ManagementAndGeneralAmt>23225</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>7177</TotalAmt>
        <FundraisingAmt>7177</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>23048</TotalAmt>
        <ProgramServicesAmt>12044</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5296</ManagementAndGeneralAmt>
        <FundraisingAmt>5708</FundraisingAmt>
      </InformationTechnologyGrp>
      <OtherExpensesGrp>
        <Desc>FAMILY CONFERENCE</Desc>
        <TotalAmt>316003</TotalAmt>
        <ProgramServicesAmt>316003</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS EXPENSES</Desc>
        <TotalAmt>40081</TotalAmt>
        <ProgramServicesAmt>9291</ProgramServicesAmt>
        <ManagementAndGeneralAmt>29302</ManagementAndGeneralAmt>
        <FundraisingAmt>1488</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BAD DEBT EXPENSE</Desc>
        <TotalAmt>30000</TotalAmt>
        <ManagementAndGeneralAmt>30000</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SCIENCE SYMPOSIUM</Desc>
        <TotalAmt>24515</TotalAmt>
        <ProgramServicesAmt>24515</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>40376</TotalAmt>
        <ProgramServicesAmt>40376</ProgramServicesAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1524547</TotalAmt>
        <ProgramServicesAmt>1222965</ProgramServicesAmt>
        <ManagementAndGeneralAmt>183779</ManagementAndGeneralAmt>
        <FundraisingAmt>117803</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>377072</BOYAmt>
        <EOYAmt>5887094</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>394613</BOYAmt>
        <EOYAmt>474095</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>102815</BOYAmt>
        <EOYAmt>830</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>35130</BOYAmt>
        <EOYAmt>13873</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <TotalAssetsGrp>
        <BOYAmt>909630</BOYAmt>
        <EOYAmt>6375892</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>84541</BOYAmt>
        <EOYAmt>40930</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>50000</BOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>11663</BOYAmt>
        <EOYAmt>9997</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>146204</BOYAmt>
        <EOYAmt>50927</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>648677</BOYAmt>
        <EOYAmt>1119042</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>114749</BOYAmt>
        <EOYAmt>5205923</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>763426</BOYAmt>
        <EOYAmt>6324965</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>909630</BOYAmt>
        <EOYAmt>6375892</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>5508764</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>52775</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc7">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>569701</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>454102</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>545602</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>580723</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>6621901</CurrentTaxYearAmt>
        <TotalAmt>8772029</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>158662</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>104145</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>377668</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>495211</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>463005</CurrentTaxYearAmt>
        <TotalAmt>1598691</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>728363</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>558247</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>923270</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1075934</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>7084906</CurrentTaxYearAmt>
        <TotalAmt>10370720</TotalAmt>
      </Total509Grp>
      <SubstantialContributorsAmtGrp>
        <CurrentTaxYearMinus1YearAmt>133062</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>133062</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus1YearAmt>133062</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>133062</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>10237658</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>12714</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>9253</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>8695</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>10162</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>11707</CurrentTaxYearAmt>
        <TotalAmt>52531</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>12714</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>9253</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>8695</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>10162</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>11707</CurrentTaxYearAmt>
        <TotalAmt>52531</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>741077</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>567500</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>931965</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1086096</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>7096613</CurrentTaxYearAmt>
        <TotalAmt>10423251</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.98220</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.95180</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.01000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.01000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc3">
      <TotalRevEtcAuditedFinclStmtAmt>7086086</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>52775</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>52775</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>7033311</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>7033311</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>1524547</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>1524547</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>1524547</TotalExpensesPerForm990Amt>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc4">
      <FundraisingEventInformationGrp>
        <Event1Nm>GALA</Event1Nm>
        <GrossReceiptsEvent1Amt>193035</GrossReceiptsEvent1Amt>
        <GrossRevenueEvent1Amt>193035</GrossRevenueEvent1Amt>
        <OtherDirectExpensesEvent1Amt>52162</OtherDirectExpensesEvent1Amt>
        <Event2Nm>BELIEVE WALKS</Event2Nm>
        <GrossReceiptsEvent2Amt>58151</GrossReceiptsEvent2Amt>
        <GrossRevenueEvent2Amt>58151</GrossRevenueEvent2Amt>
        <OtherDirectExpensesEvent2Amt>4460</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>1</OtherEventsTotalCnt>
        <GrossReceiptsOtherEventsAmt>36980</GrossReceiptsOtherEventsAmt>
        <GrossRevenueOtherEventsAmt>36980</GrossRevenueOtherEventsAmt>
        <OthDirectExpnssOtherEventsAmt>6680</OthDirectExpnssOtherEventsAmt>
        <GrossReceiptsTotalAmt>288166</GrossReceiptsTotalAmt>
        <GrossRevenueTotalEventsAmt>288166</GrossRevenueTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>63302</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>63302</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>224864</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc5">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>KICHO INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>169 MADISON AVE STE 2641</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <CashGrantAmt>500000</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>QUIVER BIOSCIENCE INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>150 CAMBRIDGEPARK DR</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02140</ZIPCd>
        </USAddress>
        <RecipientEIN>922683215</RecipientEIN>
        <CashGrantAmt>100000</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>THE DUP15 ALLIANCE REQUIRES ANNUAL FINANCIAL AND SCIENTIFIC PROGRESS REPORTING FROM ALL INVESTIGATORS AND SIGNED BY THE GRANTEE INSTITUTION.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc6">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>DUP15Q ALLIANCE EMPOWERS INDIVIDUALS LIVING WITH DUP15Q SYNDROME AND OTHER RELATED RARE DISEASES TO REACH THEIR FULL POTENTIAL BY ADVANCING BREAKTHROUGH RESEARCH AND LIFE-CHANGING THERAPEUTIC TREATMENTS, SUPPORTING FAMILIES AFFECTED BY DUP15Q, AND PROMOTING ADVOCACY. AS THE ONLY PATIENT ADVOCACY GRUP FOCUSED ON DUPLICATION 15Q SYNDROME, OUR ORGANIZATION IS DEVOTED TO ADVANCING RESEARCH INTO THE SYNDROME, SUPPORTING AND PROMOTING THE WORK OF SCIENTISTS, CLINICIANS, AND DRUG DEVELOPMENT COMPANIES IN THE SEARCH FOR TREATMENTS THAT WILL ALLEVIATE THE SERIOUS AND MULTIPLE SYMPTOMS OF THE DISORDER. WE ALSO WORK TO EDUCATE FAMILIES ABOUT THE SYNDROME, SUPPORTING THEM WITH INFORMATION, AND CONNECTING FAMILIES TOGETHER FROM THE DAY THEY FIRST REGISTER WITH US, SO THAT THEY CAN SHARE INFORMATION AND SUPPORT EACH OTHER. WE OFFER FAMILIES OPPORTUNITIES TO EDUCATE THEIR OWN FRIENDS AND FAMILIES AND THEIR COMMUNITIES ABOUT DUPLICATION 15Q SYNDROME, RAISING AWARENESS ABOUT THIS RARE CONDITION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>SCIENTIFIC AND CLINICAL INITIATIVES: THE DUP15Q ALLIANCE STANDS AT THE FOREFRONT OF COLLABORATIVE EFFORTS WITH STAKEHOLDERS IN ACADEMIC, CLINICAL, AND PHARMACEUTICAL SPACES TO ADVANCE RESEARCH INTO DUP15Q SYNDROME. IN 2025, WE FINANCIALLY SUPPORTED PARTNERSHIPS WITH TWO DIFFERENT DRUG DEVELOPMENT COMPANIES WORKING SPECIFICALLY ON TARGETED GENETIC TREATMENTS FOR DUP15Q SYNDROME. ADDITIONALLY, WE ALSO FUNDED AND AWARDED A RESEARCH GRANT TO AN ACADEMIC LAB STUDYING ONE OF THE COMPANIES' THERAPEUTIC CANDIDATES. WE DIRECTED DONATIONS TO CONTINUE A SINGLE-SITE NATURAL HISTORY STUDY INITIATED IN 2024, RECRUITING FAMILIES TO PROVIDE DATA AND BIOLOGICAL SAMPLES IN AN ONGOING STUDY OF DUP15Q AND HOW SYMPTOMS CHANGE OVER TIME. FURTHERMORE, WE WORKED TO EXPAND THE NATURAL HISTORY STUDY TO ENCOMPASS INDIVIDUALS AT OUR FAMILY CONFERENCE, AN UNDERTAKING THAT WIDENED THE ABILITY FOR OUR COMMUNITY TO PARTICIPATE IN THIS PIVOTAL STUDY. OUR BIENNIAL FAMILY CONFERENCE SAW OVER 500 MEMBERS OF THE DUP15Q SYNDROME COMMUNITY CONVENE IN INDIANAPOLIS TO CONNECT AND LEARN ABOUT WAYS THE ALLIANCE CAN SUPPORT THEM. SOME OF THE MAIN FOCUSES WERE RESEARCH, NATURAL HISTORY STUDIES, AND CLINICAL TRIALS ON THE HORIZON. WE SUPPORTED A TEAM OF COMBINEDBRAIN RESEARCHERS AT OUR CONFERENCE WHO COLLECTED BLOOD SAMPLES FROM AFFECTED INDIVIDUALS AND THEIR FAMILY MEMBERS TO SUPPORT ONGOING AND FUTURE DUP15Q RESEARCH PROJECTS. CLINICS - WE PROVIDED SUPPORT TO OUR NETWORK OF 15 CLINICS THROUGH PER- PATIENT PAYMENTS TO OFFSET COSTS OF CARE. WE ALSO SUPPORTED OUR FAMILIES THROUGH TRAVEL GRANTS AND SPECIALIZED EMERGENCY CONSULTATIONS FOR FAMILIES IN CRISIS. DUP15Q CLINICS CONNECT FAMILIES WITH HIGHLY SPECIALIZED MEDICAL PROVIDERS IN A VARIETY OF FIELDS WHO HAVE EXTENSIVE EXPERIENCE TREATING DUP15Q SYNDROME. OUR CLINICAL COLLABORATION WITH THE ANGELMAN SYNDROME FOUNDATION ALLOWS US TO EXPAND OUR CLINICAL FOOTPRINT, IMPROVE ACCESS TO CARE, AND BRING TOGETHER A LARGER GROUP OF MEDICAL AND RESEARCH PROFESSIONALS AROUND THE WORLD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4C</FormAndLineReferenceDesc>
        <ExplanationTxt>FAMILY SUPPORT IN 2025, DUP15Q ALLIANCE CONTINUED TO INCREASE PROGRAMMING TO SUPPORT INDIVIDUALS, THEIR FAMILIES AND CAREGIVERS, AS WELL AS EXTENDED SUPPORTERS. IN THE SPRING, WE LAUNCHED A REGIONAL REPRESENTATIVE PROGRAM TO PROVIDE A LOCAL CONTACT FOR DUP15Q ALLIANCE FAMILIES IN THE US. WE CURRENTLY HAVE 28 REPRESENTATIVES THAT NOT ONLY PROVIDE SUPPORT AND INFORMATION, BUT ALSO HOSTED MULTIPLE LOCAL GATHERINGS FOR DUP15Q FAMILIES TO MEET. THESE REPRESENTATIVES ARE SUPPORTED BY THE FAMILY SUPPORT MANAGER THROUGH QUARTERLY VIRTUAL MEETINGS AND QUARTERLY INFORMATIVE NEWSLETTERS THAT HELP EMPOWER THE TEAM TO ASSIST THEIR FAMILIES. WE FUNDED LICENSED CLINICAL PROFESSIONAL COUNSELOR SESSIONS SO FAMILIES IN CRISIS COULD ACCESS HELP AT NO COST. OUR FAMILY SUPPORT MANAGER PERSONALLY REACHES OUT TO NEWLY DIAGNOSED FAMILIES, GIVING THEM PERSONAL SUPPORT AND CONNECTING THEM TO THEIR COMMUNITY. IN 2025, WE HAD A RECORD NUMBER OF PARENTS ATTENDING A VARIETY OF MONTHLY VIRTUAL CONNECTION CALLS THAT ARE OFFERED THROUGHOUT EACH MONTH. THESE CALLS HELP FORM FRIENDSHIPS AMONG PARENTS WITH CHILDREN WITH DUP15Q SYNDROME, AND GIVE THEM A SAFE SPACE TO LEARN FROM ONE ANOTHER. AS A CONFERENCE YEAR, THERE WERE ONLY 2 BELIEVE FUNDRAISING WALKS - HOWEVER, THEY STILL GAVE FAMILIES THE OPPORTUNITY TO GET TOGETHER, EDUCATE FAMILY AND FRIENDS, AND RAISE FUNDS TO SUPPORT OUR MISSION. OTHER PROGRAMS WERE MAINTAINED, SUCH AS THE COMPASSION EXPERIENCE, VIP KITS, AND THE FAMILIES IN CRISIS/WRAPPED IN LOVE PROGRAM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>A COMPLETE COPY OF THE FORM 990 IS PROVIDED TO BOARD MEMBERS FOR REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS A WRITTEN CONFLICT OF INTEREST POLICY. THE DIRECTOR AND ALL OFFICERS ARE REQUIRED TO DISCLOSE ANNUALLY ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITORS AND ENFORCES COMPLIANCE WITH THE POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION OFFERS ALL OF ITS INFORMATION FOR PUBLIC INSPECTION UPON REQUEST. THE ORGANIZATION WILL REPORT ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ON THEIR WEBPAGE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>